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The depression of adrenal cortical function by exogenous steroid therapy has been recognized in adults for many years (Shuster and Williams, 1961; Treadwell et al., 1963) , and more recently adrenocortical suppression has been demonstrated in children receiving prednisolone in doses as low as 5 mg daily (Kuzemko and Lines, 1970) . There have been suggestions that, as the therapeutic action of the steroid persists for more than one day, intermittent rather than daily administration of the corticosteroid might reduce the side effects of the hormonal treatment without affecting the degree of therapeutic action, and of the various regimens tried the administration of the steroid as a single dose once every 48 hours appeared to be the most efficacious (Harter, Reddy, and Thorn, 1963) . This alternate day regimen has since been found to be beneficial with a number of steroid preparations, for example, prednisone in the treatment of renal disease in adults (Ackerman and Nolan, 1968) and in children (Soyka, 1967) , and has been reported effective with betamethasone in controlling asthma in children (Siegel et al., 1965) .
The object of the present work was to investigate whether suppression of adrenal function occurred to the same extent in asthmatic children receiving prednisolone once every 48 hours, as was found in our earlier studies (Kuzemko and Lines, 1970) on similar children treated daily with this steroid. Indeed, 4 of the children reported here had been investigated earlier and were changed from a daily to an alternate-day regimen. Adrenocortical function was assessed by the 31-24 tetracosactrin (Synacthen) test. In three children, including one changed from a daily to alternate-day schedule, the therapeutic steroid was prednisolone stearoylglycolate instead of prednisolone.
Subjects and Methods
Sixteen children with moderately severe asthma were studied on up to three separate occasions. The minimum period on alternate-day steroids was 2 months, the maximum 26 months. Prednisolone and prednisolone stearoylglycolate dosages varied between 2-5 mg and 10 mg prednisolone or 6-65 mg and 13-3 mg prednisolone stearoylglycolate administered as a single dose every 48 hours (6-65 mg prednisolone stearoylglycolate is equivalent to 3-5 mg of prednisolone-manufacturer's data). Tetracosactrin tests and the method of cortisol measurement were performed as previously described (Kuzemko and Lines, 1970 (Kuzemko and Lines, 1970) .
The results of the plasma cortisol analyses
The findings show that there is a direct correlabefore and after (I-24 tetracosactrin are given in tion between the dose of corticosteroid and depres- Table II) , however, though a normal tetracosactrin test result had been obtained after 5 months on 5 mg prednisolone daily, on reduction of the steroid to 5 mg prednisolone once every 48 hours, the incremental response to tetracosactrin after 6 months of this treatment was exactly double that which it had been previously (20 ,.tg cortisol/ 100 ml plasma compared to 10 ,ug/100 ml). In the two other instances of improvement, the response to tetracosactrin had changed from a frankly abnormal to a normal response (Case 3, Table II) at the 5 mg prednisolone dose, and from an abnormal to a partial reponse on the 10 mg prednisolone regimen (Case 5,  (Kuzemko and Lines, 1970) in which of 10 similar children receiving 5 mg prednisolone daily, 3 developed some adrenocortical suppression and a further 2 had virtually complete suppression of adrenocortical function after 4 and 9 months, respectively, of this treatment. Of the 6 children who had 10 mg prednisolone daily, all were unable to respond to tetracosactrin; in none of these cases was the incremental response to tetracosactrin as large as that obtained in the one patient given 10 mg prednisolone on alternate days.
These results suggest that alternate day steroid therapy does not produce such deleterious effects upon the adrenal cortex as a daily regimen at the same dose level. No difficulties were found in changing children from daily to alternate day dosages. Control Table I and in a child on 2 5 mg prednisolone daily), lasting 8 and 10 weeks, respectively, after complete withdrawal of steroids, so that school work was adversely affected. During alternate day therapy, behavioural ('mood') changes have not been observed in children on the days when they did not take any corticosteroids such as have been described in adults who took large doses of corticosteroids (Harter, Reddy, and Thorn, 1963) . Children requiring chronic steroid therapy appear to benefit therefore by maintenance on an alternate day instead of a daily regimen. The same is probably true in many situations for adults. Earlier reports had indicated that a similar conclusion was also applicable where corticosteroid dose levels were much higher both in children (Soyka and Saxena, 1965; Soyka, 1967) and in adults (Ackerman and Nolan, 1968 (Carter and James, 1970; James, 1970 (James, 1970; Jasani et al., 1968) , and there are some conflicting findings with the lysine-vasopressin test (Brostoff, James, and Landon, 1968 This test appears to be the most sensitive index of adrenal cortical reserve in the child, and we fully endorse the comment, which though made about adults is equally applicable to children, that 'subnormal response to p1-24 tetracosactrin requires corticosteroid "cover" during operations' (Jasani et al., 1968) ; and would add other stressful situations like infections or accidents when the patient may equally well die from hypotensive shock. Finally, an abnormal tetracosactrin test in an asthmatic child calls for a reassessment of corticosteroid therapy, e.g. reduction of the dosage, accelerated withdrawal with ACTH cover and eventual change to ACTH alone, increase of dosage during periods of stress, and use of additional non-steroid drugs. We have shown that this can be achieved, and thus sudden and unexpected deaths avoided.
